References
- Task Force on Nomenclature and Statistics of the American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association, 1980
- Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 1970;126:983–7
- Hall RC. Depression in psychiatric presentations of medical illness. In: Hall RC, ed. Psychiatric presentations of medical illness. New York: Spectrum Publications, 1980
- Overall JE, Hollister LE, Johnson M, et al. Nosology of depression and differential response to drugs. JAMA 1966;195:946–8
- Hollister LE, Overall JE, Pokorney AD, et al. Acetophenazine and diazepam in anxious depressions. Arch Gen Psychiatry 1971;24:273–8
- Paykel ES, Parker RR, Penrose RJ, et al. Depressive classification and prediction of response to phenelzine. Br J Psychiatry 1979;134:572–81
- Glowinski J, Axelrod J. Inhibition of uptake of tritiated-noradrenalin in the intact rat brain by imipramine and structurally related compounds. Nature 1964;204: 1318–9
- Mendels J. Lithium in the treatment of depression. Am J Psychiatry 1976;133:373–8
- Ayd FJ. Lithium-induced nephrotoxicity: a further report. Int Drug Ther Newsletter 1978;13(7):25–8
- Grof P, Angst J, Haines T. The clinical course of depression: practical issues. Symp Medica Holchst 1973;8:141–8
- Davis JM. Overview: maintenance therapy in psychiatry. II. Affective disorders. Am J Psychiatry 1976;133:1–13
- Weissman MM, Klerman GL, Paykel ES. Treatment effects on the social adjustment of depressed patients. Arch Gen Psychiatry 1974;30:771–8